Danaher Grabs Molecular Diagnostics Co. In $4B Cash Deal
Science and technology giant Danaher Corp. said Tuesday that it would buy California-based molecular diagnostics company Cepheid in a deal valued at about $4 billion, including debt and net cash on...To view the full article, register now.
Already a subscriber? Click here to view full article